MEMORANDUM
Global Manifesto to Save 34 Million Lives:
Measures Needed to Rapidly Expand Access to Essential Treatments for HIV/AIDS
Health before profits!
-
Sunday July 9th 2000
TO:
The Honourable Deputy President of South Africa and Chairperson of the
South African National AIDS Council, Mr. Jacob Zuma
The Honourable South African Minister of Health, Dr. Manto Tshabalala-Msimang
The Honourable South African Minister of Foreign Affairs, Dr Nkosazana
Dlamini-Zuma
Ms. Sandra Thurman, Coordinator, Director of the United States Office
of National AIDS Policy on behalf of United States President, Mr. Bill
Clinton
Mr. Michael Laidler, Ambassador of the European Union in South Africa
Dr. Harvey Bale, Director General of the International Federation of
Pharmaceutical Manufacturers Associations
Dr. Peter Piot, Executive Director of UNAIDS
Prof. Jerry Coovadia, Chairperson of the International AIDS Conference
Dr. Stefano Vella, President elect of the International AIDS Society
The Treatment Action Campaign and Health Global Access Project Coalition
(Health GAP) have mobilized the largest coalition of concerned citizens
ever assembled to insist on the right to health care and access to life-sustaining
medicines.
Our march today demanding access to treatment is the most broad-based
in the twenty-year history of the HIV epidemic. We bring before you thousands
of people from many different countries and perspectives. On our march
today are thousands of people living with HIV and AIDS, our friends and
families, as well as trade unionists, representatives of political parties,
and a wide range of non-governmental organizations. We represent organizations
and movements in over 34 countries, many of which cannot be physically
present with us today.
We are all united with a single purpose, to ensure that everyone --
including people with HIV and AIDS -- has access to their fundamental right
to health.
Underpinning our demands are several issues, which we ask you to recognize
publicly:
AIDS has become a catastrophe that threatens the very future of this planet.
Terribly high levels of HIV infection and death due to AIDS are now a reality
(rather than merely a projection) in poor communities worldwide. More than
half off all these infections occur among women. AIDS is causing widespread
devastation in Africa and Asia especially. This was avoidable. It is the
consequence of negligence, particularly on the part of First World¹
governments whose resources could have been mobilized to come to the practical
assistance of poor nations many years ago.
Scientific research has blessed us with breakthroughs in treatment and
care. These advances have resulted in a major drop in AIDS-related mortality
in rich countries, and have turned HIV infection from a certain death sentence
into a chronic disease. With few exceptions, these benefits have not been
extended to developing countries, despite the fact that more than 95% of
all people with HIV live in these nations.
These breakthroughs could be brought very quickly to benefit many millions
of lives if only the drive for profit by pharmaceutical companies
could be tempered. Profiteering from essential goods contributes to what
Gro Harlem Brundtland, Director General of the World Health Organization,
recently described as the "scandalous inequity" in access to health care.
In this regard, we note that in 1999 the combined profits of the 12 largest
pharmaceutical companies was US$27.3 billion. This amounts to a horrendous
exploitation of the needs of the poor, the sick and the vulnerable.
Access to medical treatment is essential to effective HIV prevention. People
with HIV have the right to expect access to the best treatment. To expect
anything less is to surrender.
Recognizing these truths has implications for governments of
the North and South, pharmaceutical companies, UNAIDS, and civil society.
We will ensure that history measures your response from this day onward.
We would like to address specific proposals to each of the parties we
have called here today:
1. TO THE SOUTH AFRICAN GOVERNMENT
The South African Government has a unique potential to right the wrongs
and inequalities that exist around AIDS. Not only is South Africa the worst
affected country in the world, but you have the moral legitimacy that has
accrued to a nation that has risen peacefully from apartheid, under the
leadership of former President Nelson Mandela. In your own words, AIDS
is a "new struggle". In the words of the Organisation of African Unity¹s
recently signed Ouagadougou Commitment (May 2000) "health constitutes a
right and a foundation for socio-economic development," whereas the AIDS
epidemic is a major "public health, development and security problem for
Africa."
We call on the SA Government to:
Immediately implement a country-wide program to reduce the risk of mother-to-child
transmission of HIV using AZT or neviripine.
Immediately accept and implement currently offered drug donation programs
provided there are no strings attached.
Immediately issue a compulsory license for fluconazole. This drug could
be immediately imported from the lowest-priced producers to extend the
lives and improve the quality of life of people with HIV.
Call on other developing countries to do likewise.
Demonstrate leadership and integrity in the governance of its HIV/AIDS
programs as a model for developing countries.
Campaign for the appropriate and transparent use of public funds for public
need, and especially for the development of health infrastructure.
2. TO THE GOVERNMENTS OF THE USA AND EUROPEAN UNION
People from poor countries cannot help but believe that whilst your
governments will draw massively from public funds when your own security
is threatened, the lives of poor and black people in the emerging global
village¹ are considered dispensable and unworthy of protection.
The policies of trade liberalization that you endorse and have pursued
through bodies such as the World Bank, IMF and World Trade Organization
have had a devastating impact on social services, and particularly health
services.
We demand that you:
Immediately and publicly renounce all trade sanctions or other punitive
measures against governments exercising their right to protect the health
and well-being of their populations through mechanisms such as compulsory
licensing and parallel importing.
Renounce all threats of bilateral trade sanctions against any country and
adhere to the multilateral procedures for dispute resolution to which you
are committed by treaty and international law. Least-developed countries
should not be pressured to develop intellectual property laws until the
established deadline of 2006.
Immediately offer financing to developing countries, to improve and expand
the health infrastructure, both human and capital, needed to treat HIV,
AIDS and many other causes of illness and disease. This will benefit all
people, not just those affected by HIV/AIDS
We call on the US government to extend the scope of the recently issued
US Executive Order acknowledging countries¹ rights to employ compulsory
licensing and parallel importing to protect public health to all developing
countries, not just Africa.
We call on the European Union to adopt similar measures. All these measures
should be represented not as charitable "exceptions," but as recognition
of countries¹ legitimate rights under international law.
We also demand that you provide substantial public funding for independent
scientific research to develop new therapies and find a cure. This research
should be freed from the grip of pharmaceutical companies who will exploit
it for private interest. Resulting products should remain a public trust,
and be made available to the international community. In addition to relevant
vaccine research, we consider particularly important the urgent development
of effective spermicidal and non-spermicidal microbicides. These will reduce
gender inequality and increase women¹s ability to protect themselves.
In addition we call for anti-retroviral therapies that are easier to use
by children and adults in countries where there is a shortage of food,
water and electricity.
Immediately grant licenses to international agencies to produce all HIV
medications for which governments maintain licensing rights, and provide
funding to produce these medications in quantity for developing nations.
3. TO THE INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS¹
ASSOCIATION (IFPMA)
The pricing policy defended by the IFPMA, where patent monopolies allow
your members to place essential drugs beyond the influence of market competition,
has become the cause of an unprecedented burden of illness and death. We
do not dispute your need to recover investments in research and development,
or to profit from these investments. But, in your hands, the profit motive
has led to the development of new medicines that are far out of reach of
the people who need them.
We call on all members of the IFPMA to:
Immediately reduce the price of essential anti-HIV/AIDS medications to
a level affordable to the populations of developing countries.
Publish on a drug-by-drug basis the actual costs of research and development,
active ingredients, manufacturing costs, and all other relevant information
necessary for an objective evaluation of the pricing structure for all
essential HIV/AIDS medications.
Direct the South African Pharmaceutical Manufacturers¹ Association
to withdraw its Court action against the South African Government aimed
at preventing health service transformation.
Cease all actions, whether through litigation or through pressure exerted
by other governments, aimed at preventing states from exercising their
rights to use compulsory licensing and parallel importing to protect the
health of their populations.
Negotiate with governments of developing countries in good faith, toward
serious action aimed at addressing a global health-care crisisnot with
the media, in public statements aimed at confusing cosmetic gestures with
real solutions.
WE SPECIFICALLY DEMAND THAT PFIZER, INC.:
Reduce the price of fluconazole internationally to the lowest currently
available price per 200 mg tablet by 1 October 2000, e.g. US $0.29.
Eliminate all conditions from your drug donations. Donations should apply
to all developing countries and to all relevant medical conditions, without
restriction; should be implemented without delay; and should entail no
arbitrary time limitations.
Not require any conditions that would adversely affect governments¹
efforts to employ compulsory licensing, parallel importing, or other legal
mechanisms to protect public health.
WE SPECIFICALLY DEMAND THAT BOEHRINGER INGELHEIM:
Expand your proposed donation of nevirapine for pregnant women to all developing
countries and relevant medical conditions; implement the program without
delay without arbitrary time limitations. All Boehringer Ingelheim¹s
available resources should be devoted to making this donation a meaningful
act, not a publicity stunt.
Not require any conditions that would adversely affect governments¹
efforts to employ compulsory licensing, parallel importing, or other legal
mechanisms to protect public health.
Include countries manufacturing generic versions of nevirapine in this
offer.
Reduce the price of nevirapine for users other than pregnant women.
4. TO UNAIDS
We salute the efforts made by UNAIDS and its predecessor the Global
Programme on AIDS (GPA). But they have been insufficient. In your own words
"18.8 million people around the world have died of AIDS, 3.8 million of
them children."
But we reject the manner in which you already appear to have given up
on the lives of those who today live with HIV. You say, "34.3 million are
now living with HIV, the virus that causes AIDS. Barring a miracle, most
of these will die over the next decade or so."
We do not need a miracle. We need political leadership, resolve and
action on the recognition that health is a human right. UNAIDS is vested
with this responsibility.
We therefore call on UNAIDS to:
Support national governments by beginning international procurement of
AIDS drugs, and by December 1, 2000 put out tenders to the proprietary
and generic industry for mass procurement of opportunistic infection and
HIV medicines. Consider previous vaccine and contraception procurement
projects as a guide.
In all negotiations with drug companies, consult with and ensure the participation
of states, particularly developing countries, most affected by the AIDS
pandemic. All "partnerships" should be accountable to the populations whose
lives are at stake.
With the World Bank, ensure that countries have sufficient financing (offered
without restrictive or repressive conditions) to develop a health infrastructure
appropriate to administering AIDS therapies.
5. TO THE INTERNATIONAL AIDS SOCIETY (IAS) , CLINICIANS AND RESEARCHERS
We salute your commitment to understanding HIV and to research into
treatments and vaccines.
We call on you to:
Step up this research. Also, we request that you make your voices heard
side-by-side with us in demanding additional public funding and the best
use of medicines for the greatest number of people. Silence equals complicity
when institutions that use your intellectual ability to produce medicines
that are then withheld from the people who most need them.
Publicly quantify and demand the funds you consider necessary for urgent
and relevant vaccine research, effective microbicides and anti-retroviral
therapies that are easier to use by children and adults in countries where
there is a shortage of food, water and electricity. We will actively campaign
for the necessary funding if you announce the sums needed.
Initiate and coordinate an international scientific collaboration on a
plan and timeframe for research. The alliance you have constructed behind
the Durban Declaration, which we welcome without reservation, must now
be turned to research.
--------------------------------------------------------------------------------
In conclusion we request:
An initial response from each of the parties we have addressed at the close
of the International AIDS Conference on July 14th 2000.
A detailed response to the proposals made in this Memorandum by August
8th, 2000.
Failure to satisfy us on these proposals will result in an international
day of action on December 10th, International Human Rights Day.
We conclude with the words of the Gro Harlem Brundtland, Director General
of the World Health Organization, who stated in an address to the Parliament
of Brazil earlier this year,
"investing in health is a measurable, results-oriented and effective
way to reduce poverty access for all to essential drugs and vaccines
is also a short cut to lower mortality and better health for the entire
population. Improving such access is among the most effective health interventions
any country can make. Health is not a peripheral issue that only more affluent
economies can afford to spend money on. It is a central element of development.
And access to drugs is an essential element of any health policy."
--------------------------------------------------------------------------------
The millions of people who stand behind our call are awaiting a
meaningful response to these demands. We will not go away.